Skip to main content

Blog

WATCH: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy (Webinar Recording)

...

2024 Rev It Up 5k Raises $27,000 for PPMD

...

PPMD Hosts Meeting Exploring the Case for Cardiac Transplantation in Duchenne

...

PPMD Joins Duchenne Parent Project aps Respiratory International Professional Care Meeting

...

Catch Up on Our PPMD Together Event in Seattle, Washington

...

Capricor Therapeutics Plans to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Cardiomyopathy

...

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Individuals With Duchenne Amenable to Exon 53 Skipping

...

Thanks to You PPMD Continues Forward in All Areas of Support

...

PPMD Contributes to National Academies Report on Rare Disease Regulatory Processes

...

PPMD Community Webinar Recap: Overview of DUVYZAT and Access Resources

...